RecruitingNot ApplicableNCT06979154

Pilot Study of Personalized Aperiodic Transcranial Alternating Current Stimulation in Antenatal Depression (PandA-tACS)

Pilot Study Using Endogenous Aperiodic Brain Activity to Personalize Transcranial Alternating Current Stimulation as a Treatment for Antenatal Depression: PandA-tACS


Sponsor

University of North Carolina, Chapel Hill

Enrollment

10 participants

Start Date

Aug 12, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to develop the safety, feasibility, and tolerability of a personalized transcranial alternating current stimulation (tACS) approach in antenatal depression.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a personalized type of brain stimulation called aperiodic tACS (transcranial alternating current stimulation) as a treatment for depression during pregnancy (antenatal depression). The stimulation is customized to each person's brain activity patterns and is non-invasive. **You may be eligible if...** - You are a woman between 18 and 45 years old - You are between 14 and 32 weeks pregnant with a single baby - You have a diagnosis of major depressive disorder (non-psychotic) confirmed by assessment - Your depression score on the HDRS-17 scale is 14 or higher - You have low suicide risk (no active suicidal thoughts in the past month) - You are receiving obstetric care at the study institution **You may NOT be eligible if...** - You have a history of bipolar disorder, schizophrenia, or psychosis - You have autism spectrum disorder - You have severe alcohol use disorder or moderate-to-severe drug use disorder in the past year - You have started a new psychiatric medication or therapy in the past 6 weeks - You have previously received brain stimulation treatment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEtACS (aperiodic)

Individualized tACS waveform based on aperiodic EEG activity will be delivered.


Locations(1)

Carolina Center for Neurostimulation

Chapel Hill, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06979154


Related Trials